Categories AlphaGraphs, Earnings, Health Care

Earnings Summary: Highlights of Humana’s Q2 2024 report

Humana Inc. (NYSE: HUM), a leading health and well-being company, reported a decrease in adjusted earnings for the second quarter of 2024 when its revenues grew in double digits.

  • Second-quarter earnings, on an adjusted basis, dropped to $6.96 per share from $8.94 per share in the prior-year quarter
  • Including special items, Q2 net income came in at $5.62 per share, vs. $7.66 per share in the same period last year
  • June quarter revenues increased to $29.54 billion from $26.75 billion in the year-ago quarter
  • The management revised its FY2024 EPS guidance, on a reported basis, to about $12.81 from the previous forecast of $13.93
  • The company affirmed its full-year adjusted earnings guidance at $16.00 per share, and the Insurance segment benefit ratio at around 90%
  • As of June 30, 2024, days in claims payable was 41.6 days, which represents a decrease of 0.9 day from March 31, 2024

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top